An interventional study of Bone-Patellar tendon-Bone and Patellar tendon-Bone in Anterior Cruciate Ligament (ACL) Reconstruction and Anterior Cruciate Ligament Injury, sponsored by Universidad de Granada. Recruiting at 1 site in Spain. Open to participants aged 12 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-03-23.
Sponsored by Universidad de Granada · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Anterior Cruciate Ligament Injuries with a site in Spain — 6 open to participants now, 7 under way, none of them phase 3. Anterior Cruciate Ligament Injuries · Spain.
Among the 12 studies in Anterior Cruciate Ligament Injuries with a site in Spain, this one is the 2nd largest by planned enrollment of the 10 interventional ones that give a count, is one of 3 that started in 2026, is one of 10 with no phase, and was the 11th registered.
627 studies on the registry are indexed under Anterior Cruciate Ligament Injuries; 193 are open to participants now.
Browse Anterior Cruciate Ligament Injuries studies →6 of the 12 studies in Anterior Cruciate Ligament Injuries with a site in Spain are open now. Recruiting first, the newest first:
Hospital Clinic of Barcelona · Sites in Spain
Ages 18–50
University of Las Palmas de Gran Canaria · Sites in Spain
Ages 16+
Universitat de Lleida · Sites in Spain
Ages 18–65 · Men only · Healthy volunteers
Universidad Católica San Antonio de Murcia · Sites in Spain
Ages 16–35 · Women only
Amanda Coves García · Sites in Spain
Ages 18–35 · Women only
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 122 Anterior Cruciate Ligament Injuries studies recruiting now, 27 (22%) set no upper age limit and 92 (75%) stop at 75 or younger; 46 take children under 18; 21 take healthy volunteers.
This study: 12 Years to 40 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
First in 2019; this study’s year is marked. 3 started in 2026.
This study's planned enrollment of 110 is above the median of 56 across 460 interventional studies indexed under Anterior Cruciate Ligament Injuries.
Median enrollment 44 across the 10 interventional studies, 106 across the 2 observational. Of the 3 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 12 has an industry lead sponsor. The 10 most frequent:
Universidad de Granada is the lead sponsor of 246 studies on the registry; 43 are open to participants now.
Universidad de Granada has 2 studies filed under Anterior Cruciate Ligament Injuries — fewer than ten, so there is no comparison to draw.
2 of the studies in Anterior Cruciate Ligament Injuries with a site in Spain that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06621355Universitat de LleidaA Paradigm Shift in Musculoskeletal Rehabilitation Assessment After ACL Reconstruction Using Near-Infrared Spectroscopy | 2026-12-30 |
| NCT07475351Universidad de GranadaComparison of Bone-patellar Tendon-bone and Patellar Tendon-bone Grafts in ACL Reconstruction | 2027-03 |
Add all 2 to your calendar (.ics) → With an account.
Among the 12 studies in Anterior Cruciate Ligament Injuries with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this randomized study is to compare donor site morbidity and clinical and functional outcomes of both surgery techniques (bone-patellar tendon-bone (BPTB) graft versus bone-patellar tendon without patellar bone plug (PT) graft) for anterior cruciate ligament reconstruction (ACLR) in athletes. The main questions it aims to answer are:
Patients will:
Anterior cruciate ligament (ACL) rupture is the most prevalent type of knee ligament injury, representing approximately 50% of all reported knee injuries. This injury has a particularly high impact on most athletes due to the demands of pivoting, jumping and cutting movements required during play. In addition, its consequences include a prolonged recovery period, the risk of reinjury and complications arising from ACL insufficiency, such as knee instability, meniscal tears or osteoarthritis. Given that the primary indicator of successful treatment is the athlete's ability to return to competitive levels, surgical reconstruction of the ACL (ACLR) has become the standard treatment. However, the choice of the optimal graft for ACLR remains controversial. For many authors, bone-patellar tendon-bone (BPTB) graft is considered gold-standard option due to optimal biomechanical properties and low reinjury rate. However, BPTB is usually associated with donor site morbidity, specifically related to kneeling, dysesthesia and anterior knee pain.
Given the disadvantages of the BPTB graft, an ACLR based on a bone-patellar tendon graft may be a viable alternative. This technique utilizes an autograft composed of the central third of the patellar tendon and a tibial tubercle bone plug without inclusion of the patellar bone plug, called bone-patellar tendon (BPT). Previous studies have demonstrated lower rates of anterior knee pain in BPT compared to BPTB. However, there is a lack of evidence regarding objective and specific donor site morbidity assessment for both techniques.
The main hipothesis of this study is that BPT has similar clinical an functional recovery compared to BPTB with lower rates of anterior knee morbidity.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Procedure: Patellar tendon-Bone
Procedure: Bone-Patellar tendon-Bone
After an arthroscopic examination via an anterolateral viewing portal to confirm the ACL injury, two additional portals will be established: an accessory medial portal slightly above the joint line (approximately 2cm from the medial border of the patellar tendon) and a high anteromedial portal. Once associated lesions are addressed, the graft is harvested through a 6cm longitudinal midline incision. Following paratenon dissection, the patellar tendon dimensions are measured: * Minimum length: 42mm * Width-based harvesting: if the tendon width is \<30mm, a graft consisting of one-third of the total width is harvested. If the width exceeds 30mm, a 10mm wide graft is obtained. * Bone plugs: patellar and tibial bone plugs (10x20x8mm) are harvested. While the graft is prepared, anatomic tunnels are created. The graft is secured with MectaScrew (MEDACTA) interference screws. Once fixed, an extra-articular tenodesis is performed using Arnold \& Coker technique.
After an arthroscopic examination via an anterolateral viewing portal to confirm the ACL injury, two additional portals will be established: an accessory medial portal slightly above the joint line (approximately 2cm from the medial border of the patellar tendon) and a high anteromedial portal. Once associated lesions are addressed, the graft is harvested through a 6cm longitudinal midline incision. Following paratenon dissection, the patellar tendon dimensions are measured: * Minimum length: 42mm * Width-based harvesting: if the tendon width is \<30mm, a graft consisting of one-third of the total width is harvested. If the width exceeds 30mm, a 10mm wide graft is obtained. * Bone plugs: a tibial bone plug (10x20x8mm) is harvested. While the graft is prepared, anatomic tunnels are created. The graft is secured with MectaScrew (MEDACTA) interference screws. Once fixed, an extra-articular tenodesis is performed using Arnold \& Coker technique.
Also known as: Patellar tendon
Donor Site Morbidity
Anterior Cruciate Ligament Donor-site Morbidity Questionnaire will be used to evaluate complications at the harvest site. Scores range from 0 to 100 points, where higher scores indicates better ouctome (absence of donor-site complications).
Time frame: At 3, 8, 12 and 24 months after surgery
Function and activity level
Lysholm-Tegner score will be used to report knee function and activity level. Scores range from 0 to 100 points, where 100 indicates a better outcome (knee function).
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Subjective knee status
International Knee Documentation Committee (IKDC) will be used to assess knee signs and symptoms. Total scores range from 0 to 100 points, where a higher score indicates a better outcome (absence of symptoms and maximum functional level).
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Psychological readiness
Anterior cruciate ligament - Return to Sport after Injury (ACL-RSI) Scale will be used to evaluate psychological readiness of patients to return to sport after ACL reconstruction. Scores range from 0 to 100 points, where a higher score indicates better outcome (full psychological readiness and confidence).
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Joint Awareness
Forgotten Joint Score (FJS) will be used to assessthe patient's ability to forget their affected joint during activities. Scores range from 0 to 100 points, where higher scores indicate a better outcome (patients "forget" the joint, representing a natural feel).
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Patient-reported symptoms
Cincinnati Knee Rating System will be used to ievaluate patient-reported symptoms. scores range from 0 to 100 points, where a higher score (100) indicates better outcome (excellent clinical result, no symptoms, and full return to sports).
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Quadriceps strength
Isokinetic test will be used to evaluate quadriceps peak torque and limb symmetry index. After a warm-up of 10 minutes, patients will perform 5 and 10 unilateral repetitions at 60 and 180º/s respectively, with one minute of rest between series.
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Hamstrings strength
Isokinetic test will be used to evaluate hamstrings peak torque and limb symmetry index. After a warm-up of 10 minutes, patients will perform 5 and 10 unilateral repetitions at 60 and 180º/s respectively, with one minute of rest between series.
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Hamstring/Quadriceps ratio
HQ ratio will be calculated with hamstring and quadriceps peak torque from isokinetic tests.
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Functional Hop Test Battery
A series of four hop tests will be performed to measure dynamic stability and neuromuscular control. Distance and limb symmetry index will be registered.
Time frame: Baseline (Pre-intervention) and 8, 12 and 24 months after surgery
Donor-site pain pressure threshold
Pain pressure threshold measured via digital algometry will be used at the patellar tendon.
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Quadriceps thickness
An ultrasound system with a linear probe will be used to measure quadriceps thickness.
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Patellar tendon morphology
An ultrasound system with a linear probe will be used to measure patellar tendon thickness and cross-sectional area.
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Anteroposterior knee stability
A Lachmeter system will be used to evaluate anteroposterior knee stability
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Knee stability
A KIRA system will be used to evaluate anteroposterior and rotational knee stability
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Height
A tallimeter will be used to register height, expressed in meters (m).
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Weight
Bioelectrical impedance analysis (BIA) will be performed by using an Inbody 970 for measuring weight, expressed in kilograms (kg).
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Body Mass Index (BMI)
Bioelectrical impedance analysis (BIA) will be performed by using an Inbody 970 for measuring BMI, expressed in kg/m\^2.
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Percentage of Body Fat
Bioelectrical impedance analysis (BIA) will be performed by using an Inbody 970 for measuring PBF, expressed in %.
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Skeletal Muscle Mass
Bioelectrical impedance analysis (BIA) will be performed by using an Inbody 970 for measuring SMM, expressed in kg.
Time frame: Baseline (Pre-intervention) and 3, 8, 12 and 24 months after surgery
Plan to share: No
No publications or documents are linked to this record.
Started Jan 2026 (actual). Primary completion is estimated for Mar 2027, 14 months after the start.
Of 279 non-industry interventional studies with no phase under Anterior Cruciate Ligament Injuries, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 70. This study's planned 14 months is below that.
Counting every sponsor, half of 288 studies reached it within 30 months; a quarter within 14 and three quarters within 70.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Anterior Cruciate Ligament Injuries →